Published online Jul 16, 2021. doi: 10.12998/wjcc.v9.i20.5752
- This corrects the article "Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases".
Peer-review started: January 11, 2021
First decision: April 29, 2021
Revised: May 7, 2021
Accepted: May 24, 2021
Article in press: May 24, 2021
Published online: July 16, 2021
Processing time: 176 Days and 20.2 Hours
Correction to: Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 2020; 8: 1361-1384. We are the team of Min Jiang and Li-Xuan Sang from the First Affiliated Hospital, China Medical University. Now we solemnly declare that the studies mentioned in this article[1] evaluated the probiotic formulation known as VSL#3 before January 31, 2016. The probiotic formulation is now commonly referred to as De Simone Formulation. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome in the United States and Vivomixx in Europe.
Core Tip: This manuscript is to further explain VSL#3 mentioned in it for probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases (World J Clin Cases 2020; 8: 1361-1384).
- Citation: Sang LX. Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”. World J Clin Cases 2021; 9(20): 5752-5753
- URL: https://www.wjgnet.com/2307-8960/full/v9/i20/5752.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i20.5752
Correction to: Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases 2020; 8: 1361-1384 PMID:
We are the team of Min Jiang and Li-Xuan Sang from the First Affiliated Hospital, China Medical University. We published an article about probiotic mixture VSL#3 on April 26, 2020. Now we solemnly declare that the studies mentioned in this article[1] evaluated the probiotic formulation known as VSL#3 before January 31, 2016. The probiotic formulation is now commonly referred to as De Simone Formulation. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome in the United States and Vivomixx in Europe.
| 1. | Cheng FS, Pan D, Chang B, Jiang M, Sang LX. Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases. World J Clin Cases. 2020;8:1361-1384. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 50] [Cited by in RCA: 93] [Article Influence: 15.5] [Reference Citation Analysis (4)] |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Manuscript source: Unsolicited Manuscript
Specialty type: Gastroenterology and Hepatology
Country/Territory of origin: China
Peer-review report’s scientific quality classification
Grade A (Excellent): 0
Grade B (Very good): B
Grade C (Good): 0
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Chae Y S-Editor: Zhang L L-Editor: A P-Editor: Yuan YY